You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023194012
Dec 20235107
Jan 20249208
Feb 20245204
Mar 20245402
Apr 20244402
May 20245407
Jun 20245403
Jul 20246605
Aug 20243402
Sep 20243301
Oct 202478011
Nov 202486018
Dec 202426014
Jan 20252607
Feb 20252209
Mar 2025008
Apr 2025001
May 2025004
Jun 2025204
Total9680129